Dr. Arteaga obtained his MD degree at the University of Guayaquil in Ecuador. He trained in Internal Medicine and Medical Oncology at Emory University and the University of Texas Health Sciences Center San Antonio, respectively. He joined Vanderbilt in 1989 where he served as Professor of Medicine and Cancer Biology.
Dr. Arteaga former Director of the Center for Cancer Targeted Therapies and the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center (VICC) is currently Associate Dean of Oncology at Lisa K. Simmons Distinguished Chair in Comprehensive Oncology. He has over 300 publications in the areas of signaling by growth factor receptors and oncogenes in breast tumor cells, development of targeted therapies and biomarkers of drug action and resistance, and investigator-initiated clinical trials in breast cancer.
Since 2002, he has directed the NCI-funded Vanderbilt Breast Cancer SPORE where he co-leads several investigator-initiated clinical trials.
He has chaired the AACR Special Conference ‘Advances in Breast Cancer Research’ since 2003 and has served as AACR co-chair of the annual San Antonio Breast Cancer Symposium since 2009. He serves in the advisory boards of several academic Breast Cancer Programs and NCI-designated Cancer Centers.
Finally, he served as the 2014-2015 President of the American Association for Cancer Research, the largest cancer research organization in the world.